SEC Form 4 · accession 0001209191-18-032373
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A. Barbarosh
Director
Period of report
May 18, 2018
Accepted (ET)
May 22, 2018 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.34 | May 18, 2018 | A | 30,000 | A | — | May 17, 2028 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1Vests in four equal installments on each of the first four anniversaries of the grant date, subject to continued service to the Issuer through the applicable vesting dates.